Exploring leukocyte O-GlcNAcylation as a novel diagnostic tool for the earlier detection of type 2 diabetes mellitus

Journal of Clinical Endocrinology and Metabolism

Volumn 97, Issue 12, 2012, Pages 4640-4649

  Springhorn, Clare ^a   Matsha, Tandi E ^b   Erasmus, Rajiv T ^c   Essop, M Faadiel ^a  

^a STELLENBOSCH UNIVERSITY   (South Africa)

^b CAPE PENINSULA UNIVERSITY OF TECHNOLOGY   (South Africa)

^c UNIVERSITY OF STELLENBOSCH   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLGLUCOSAMINIDASE; CD45 ANTIGEN; GLUCOSE; HEMOGLOBIN A1C; HEXOSAMINE; N ACETYLGLUCOSAMINE; N ACETYLGLUCOSAMINE TRANSFERASE; TRANSFERASE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CELL DIFFERENTIATION; CELL ISOLATION; CONTROLLED STUDY; EARLY DIAGNOSIS; FEMALE; FLOW CYTOMETRY; GRANULOCYTE; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE MICROSCOPY; IMPAIRED GLUCOSE TOLERANCE; INSULIN RESISTANCE; LEUKOCYTE; LYMPHOCYTE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; O GLCNACYLATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN MODIFICATION; SOUTH AFRICA;

ACETYLGLUCOSAMINE; ACYLATION; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; EARLY DIAGNOSIS; FASTING; FEMALE; FLOW CYTOMETRY; GLYCOSYLATION; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; LEUKOCYTES; MALE; MIDDLE AGED; N-ACETYLGLUCOSAMINYLTRANSFERASES; PREDIABETIC STATE; PROTEIN PROCESSING, POST-TRANSLATIONAL;

EID: 84870731979     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2012-2229     Document Type: Article

References (32)

1. Wild S, Roglic G, Green A, Sicree R, King H 2004 Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 27:1047-1053 (Pubitemid 38579764)
2. Slawson C, Copeland RJ, Hart GW 2010 O-GlcNAc signaling: a metabolic link between diabetes and cancer? Trends Biochem Sci 35:547-555
3. Morgan CL, Currie CJ, Peters JR 2000 Relationship between diabetes and mortality: a population study using record linkage. Diabetes Care 23:1103-1107 (Pubitemid 30616796)
4. Boudina S, Abel ED 2007 Diabetic cardiomyopathy revisited. Circulation 115:3213-3223 (Pubitemid 47012236)
5. Pecoraro RE, Reiber GE, Burgess EM 1990 Pathways to diabetic limb amputation. Basis for prevention. Diabetes Care 13:513-521 (Abstract) (Pubitemid 20145956)
6. Centers for Disease Control and Prevention 2011 National diabetes fact sheet: national estimates and general information on diabetes and pre diabetes in the United States. Atlanta: Centers for Disease Control and Prevention http://www.cdc.gov/diabetes/pubs/factsheet11.htm
7. Saudek CD, Herman WH, Sacks DB, Bergenstal RM, Edelman D, Davidson MB 2008 A new look at screening and diagnosing diabetes mellitus. J Clin Endocrinol Metab 93:2447-2453 (Pubitemid 352008502)
8. Olson DE, Rhee MK, Herrick K, Ziemer DC, Twombly JG, Phillips LS 2010 Screening for diabetes and pre-diabetes with proposed A1C-based diagnostic criteria. Diabetes Care 33:2184-2189
9. George JA 2011 Should haemoglobin A1c be used for the diagnosis of diabetes mellitus in South Africa? J Endocrinol Metab Diabetes South Africa 16:122-127
10. Zemlin AE, Matsha TE, Hassan MS, Erasmus RT 2011 HbA1c of 6.5% to diagnose diabetes mellitus-does it work for us? The Bellville South Africa study. PLoS One 6:e22558
11. Malkani S, DeSilva T 2012 Controversies on how diabetes is diagnosed. Curr Opin Endocrinol Diabetes Obes 19:97-103
12. Cox ME, Edelman D 2009 Tests for screening and diagnosis of type 2 diabetes. Clin Diabetes 27:132-138
13. Harris MI, Klein R, Welborn TA, Knuiman MW 1992 Onset of NIDDM occurs at least 4-7 yr before clinical diagnosis. Diabetes Care 15:815-819
14. King H, Aubert RE, Herman WH 1998 Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care 21:1414-1431 (Pubitemid 28405191)
15. Rajamani U, Essop MF 2010 Hyperglycemia-mediated activation of the hexosamine biosynthetic pathway results in myocardial apoptosis. Am J Physiol Cell Physiol 299:C139-C147
16. Du X, Matsumura T, Edelstein D, Rossetti L, Zsengellér Z, SzabóC, Brownlee M 2003 Inhibition of GAPDH activity by poly(ADP-ribose) polymerase activates three major pathways of hyperglycemic damage in endothelial cells. J Clin Invest 112:1049-1057 (Pubitemid 38056320)
17. Lefebvre T, Dehennaut V, Guinez C, Olivier S, Drougat L, Mir AM, Mortuaire M, Vercoutter-Edouart AS, Michalski JC 2010 Dysregulation of the nutrient/stress sensor O-GlcNAcylation is involved in the etiology of cardiovascular disorders, type-2 diabetes and Alzheimer's disease. Biochim Biophys Acta 1800:67-79
18. Wang Z, Park K, Comer F, Hsieh-Wilson LC, Saudek CD, Hart GW 2009 Site-specific GlcNAcylation of human erythrocyte proteins: potential biomarker(s) for diabetes. Diabetes 58:309-317
19. Love DC, Hanover JA 2005 The hexosamine signaling pathway: deciphering the "O-GlcNAc code." Sci STKE 2005:re13
20. Kreppel LK, Blomberg MA, Hart GW 1997 Dynamic glycosylation of nuclear and cytosolic proteins. Cloning and characterization of a unique O-GlcNAc transferase with multiple tetratricopeptide repeats. J Biol Chem 272:9308-9315 (Pubitemid 27154943)
21. Gao Y, Wells L, Comer FI, Parker GJ, Hart GW 2001 Dynamic O-glycosylation of nuclear and cytosolic proteins: cloning and characterization of a neutral, cytosolic β-N-acetylglucosaminidase from human brain. J Biol Chem 276:9838-9845
22. Issad T, Masson E, Pagesy P 2010O-GlcNAc modification, insulin signaling and diabetic complications. Diabetes Metab 36:423-435
23. Wells L, Whelan SA, Hart GW 2003O-GlcNAc: a regulatory posttranslational modification. Biochem Biophys Res Commun 302:435-441
24. Comer FI, Vosseller K, Wells L, Accavitti MA, Hart GW 2001 Characterization of a mouse monoclonal antibody specific for O-linked N-acetylglucosamine. Anal Biochem 293:169-177 (Pubitemid 32547901)
25. Madsen-Bouterse SA, Xu Y, Petty HR, Romero R 2008 Quantification of O-GlcNAc protein modification in neutrophils by flow cytometry. Cytometry A 73:667-672 (Pubitemid 351930754)
26. Kneass ZT, Marchase RB 2004 Neutrophils exhibit rapid agonist-induced increases in protein-associated O-GlcNAc. J Biol Chem 279:45759-45765 (Pubitemid 39491567)
27. Himmelfarb J, Hakim RM, Holbrook DG, Leeber DA, Ault KA 1992 Detection of granulocyte reactive oxygen species formation in whole blood using flow cytometry. Cytometry 13:83-89
28. Golks A, Guerini D 2008 The O-linked N-acetylglucosamine modification in cellular signalling and the immune system. 'Protein modifications: beyond the usual suspects' review series. EMBO Rep 9:748-753
29. Golks A, Tran TT, Goetschy JF, Guerini D 2007 Requirement for O-linked N-acetylglucosaminyltransferase in lymphocytes activation. EMBO J 26:4368-4379 (Pubitemid 47587656)
30. Hart GW, Housley MP, Slawson C 2007 Cycling of O-linked β-N-acetylglucosamine on nucleocytoplasmic proteins. Nature 446:1017-1022 (Pubitemid 46676063)
31. Sánchez R, Concha M, Ichikawa T, Henkel R, Schill WB 1996 Glass wool filtration reduces reactive oxygen species by elimination of leukocytes in oligozoospermic patients with leukocytospermia. J Assist Reprod Genet 13:489-494 (Pubitemid 26238800)
32. Park K, Saudek CD, Hart GW 2010 Increased expression of β-N-acetylglucosaminidase in erythrocytes from individuals with prediabetes and diabetes. Diabetes 59:1845-1850